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Three-dimensional bio-printing
Abstract

Three-dimensional (3D) printing technology has been widely used in various manufacturing operations
including automotive, defence and space industries. 3D printing has the advantages of personalization,
flexibility and high resolution, and is therefore becoming increasingly visible in the high-tech fields. Threedimensional bio-printing technology also holds promise for future use in medical applications. At present 3D
bio-printing is mainly used for simulating and reconstructing some hard tissues or for preparing drug-delivery
systems in the medical area. The fabrication of 3D structures with living cells and bioactive moieties spatially
distributed throughout will be realisable. Fabrication of complex tissues and organs is still at the exploratory
stage. This review summarize the development of 3D bio-printing and its potential in medical applications, as
well as discussing the current challenges faced by 3D bio-printing.
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Three-dimensional (3D) printing technology has been widely used in various manufacturing operations including automotive,
defence and space industries. 3D printing has the advantages of personalization, flexibility and high resolution, and is therefore
becoming increasingly visible in the high-tech fields. Three-dimensional bio-printing technology also holds promise for future
use in medical applications. At present 3D bio-printing is mainly used for simulating and reconstructing some hard tissues or
for preparing drug-delivery systems in the medical area. The fabrication of 3D structures with living cells and bioactive moieties spatially distributed throughout will be realisable. Fabrication of complex tissues and organs is still at the exploratory stage.
This review summarize the development of 3D bio-printing and its potential in medical applications, as well as discussing the
current challenges faced by 3D bio-printing.
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Three-dimensional (3D) printing, also called rapid prototyping (RP), can be used to model and fabricate a
three-dimensional object layer by layer. This involves
computer or software aided design (CAD) and the printer
transferring the signals into actions to fabricate the desired
items with inkjet materials. Three-dimensional printing
emerged from stereolithography (SLA) [1]. With SLA materials are sensitive to light or laser undergoing photon initiated solidification. The whole model is accomplished after
all layers are formed [2]. Other 3D printing technologies are
now available, including fused deposition modelling (FDM),
selective laser sintering (SLS), digital light processing
(DLP), three-dimensional printing (3DP), laminated object
manufacturing (LOM), and polyjet (Table 1). Whatever the
technology is, the basic theory is that the object consists of
finite layers, and the greater the numbers of layers, the
higher the resolution required [3]. There are different
*Corresponding author (email: gwallace@uow.edu.au; zhouqi@ioz.ac.cn)

methods to fix the layers, some materials can be melted and
coagulated easily, some can be laser moulded, and some can
be easily coagulated. A complete 3D printing system contains software, to design moulds and operate, and a printer,
the main part of the system. The printer can achieve inkjet
and fabrication [46]. In China, it has been reported that the
house could be printed, so the time, cost and pollution
would be reduced (http://www.theguardian.com/). Additionally, 3D printing technique has been used to print batteries to precisely control the morphology of electrodes and
to improve the capacity of the battery (http://3dprint.com/).
Compared to traditional fabrication technology, the advantage of 3D printing is high resolution and individuation
and it has been widely used in various areas including
consumer products, film making and games [7].
With the development of biomaterials and cell biology,
bionic medicine and regenerative medicine are becoming
important research fields with fast growth. Bionic bones and
cochlear have come into the market already and bionic eyes
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Table 1
Names
SLA
FDM
SLS
DLP
3DP
LOM
Polyjet
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Types of 3D printing technology
Description
Stereolithography: light sensitive materials could be solidified to a thin layer.
Fused deposition modelling: a fundamental 3D printing technology and is used
extensively.
Selective laser sintering: similar to SLA, but solidify materials with the aid of
infrared laser.
Digital light processing: similar to SLA, but is faster because of whole layer
fabrication after laser scanning.
Three-dimensional printing: using binder, the powders are bond together to
format a whole layer.
Laminated object manufacturing: the materials are fused by heating roller.
Similar to SLA, many tips and ultraviolet lights work together. Inkjet and solidification could be accomplished simultaneously with higher resolution.

and hearts are in development. 3D printing has been used in
fabricating hard-tissues which suit the damaged sites individually. With the involvement of cells, more complex organ could be printed. Here we review the application of 3D
printing in biological and medical fields, summarize printing strategies and analyze the current issues of 3D
bio-printing. Finally, we discuss the challenges of 3D
bio-printing for future research.

1 3D bio-printing
3D printing technology used in biomedical field is denoted
3D bio-printing and it has a great potential for future regenerative therapy. An ideal 3D bio-printing system is shown
schematically in Figure 1. Firstly, accurate information of
tissues and organs should be collected for designing the
model. Secondly, the server should be able to transfer the
information into electrical signal to control the printer to
print the tissues, and the printer should be able to maintain
the cell viability during the fabrication process (Figure 1B
and C). Usually, a tissue is composed of many types of cells
and the cells will be mixed with some substances to be better fused (Figure 1C) [1416]. At present, some hard tissues
can be fabricated with bionic materials by 3D printer [17],
and have been used in clinical trials. A real complicated
tissue cannot be constructed from 3D printer at the moment.
In the future, 3D bio-printer could be used to print organs
for repairing the damaged body part, and to simulate some
functional tissues for research, therapy and drug screening.
Furthermore, 3D bio-printing can be used for personalized
therapy that could reduce the cost of therapy. Biocompatible
and biodegradable materials can be combined with 3D
bio-printing to reduce the incompatibilities caused by materials [15,18]. Therefore, 3D bio-printing will lead to a novel
technology revolution.
1.1 History of 3D bio-printing and types of 3D
bio-printing technology
3D printing is being acknowledged by more and more people, and that in turn will promote the development of the

Materials
Thermoplastics

Ref.
[2]

Plastics and some foods

[8]

Plastics, wax, ceramic and metal materials

[9]

Photopolymer

[10]

Plaster

[11]

Paper, ceramic and metal materials

[12]

Thermoplastics

[13]

technology. 3D printing can benefit the bio-therapy field as
well. It has been reported that only 20% of patients who
wait for organ donation for grafting therapy can have organs
to transplant, and the other patients have to keep waiting or
are treated by alternative and often less appropriate therapy
(http://www.unos.org/index.php). The history of tissue and
organ culture in vitro is nearly 30 years old [19]. Langer and
Vacanti [20] invented the technology of combining cells
and materials. Tissue engineered organs would be a source
of organs for transplantation in the future, but at present
there have been no acceptable artificial organs for clinical
trial. There are some successful cases in skin allograft trials,
and tissues simply constructed in vitro, such as bladder,
myocardial membrane and trachea, have also been used
clinically [2124]. But these tissues are two-dimensional
cell sheets rather than 3D structure of dermis or epidermis
[25]. Current 3D tissue fabrications have been achieved by
adding cells to the specially formatted scaffolds [2629].
3D scaffolds can provide extracellular matrix to improve
cell growth and interactions. The bio-degradable and biocompatible solid freeform fabrication (SFF) scaffolds have
been used in tissue fabrication in vitro. Some SFF scaffolds
can be built up with the help of computers to improve their
accuracy and personalization [30]. Fusion of materials and
cells can produce simple 3D dermis-like tissues, which,
however, are only used in animal models [27]. With advanced equipment and formulation protocols, some tissues
containing vessels can now be fabricated [31].
3D printing can do a better job than the above mentioned,
with the printed-out scaffolds being able to accurately depict the complicated bio-tissues and the cells being planted
on them after fabrication is completed. Cells and tissues can
also be printed simultaneously after encapsulating cells in
materials. 3D bio-printing is a super multi-discipline technology involving tissue biology, cell biology, computer
technology, materials science and medical sciences. The
printed organs should meet the requirements of all these
disciplines. At present, there are four types of 3D
bio-printing technology which are derived from basic 3D
printing techniques for depositing cells: valve-based, direct
inkjet, acoustic and laser-mediated (Figure 2).
A valve-based 3D bio-printer controls the droplets size
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Figure 1 The diagram of ideal 3D bio-printing. A, Server, which is responsible for designing the model. B, 3D bio-printer, the main facility responsible for
printing. C, The sources of different types of cells.

Figure 2 Four types of 3D bio-printing technology for depositing cells. A, Valve-controlled 3D bio-printing. B, Direct inkjet 3D bio-printing. C, Acoustic
3D bio-printing. D, Laser-mediated 3D bio-printing.

by modifying pulses (Figure 2A). Its resolution and
throughput are both at moderate level. At present, it is
mainly used in single cell sequencing and minute cell sample analysis [32].
Inkjet is a non-contact image reconstruction technology.
The signals can reappear on the platform through ink droplets (Figure 2B). The technology has been widely used in
electrical materials and integrated circuits [33]. Printing
accuracy and specificity may be improved by manipulating
ink droplets from microliter to picoliter. The technology has
been applied to printing tissue-scaffolds and bio-materials.
The difficulty is how to control the size and the flow continuity of the ink droplets [34,35]. Hydrodynamics needs to
be considered here. Methods used by inkjet technology include piezoelectric ceramics and thermal conductivity. The
technology can be used in high-throughput bio-printing but
it is difficult to achieve control over single cells [36].

Laser-mediated bio-printing is a technology mediated by
laser to position the cells of cell suspensions and tissue suspensions (Figure 2C). It is a commonly used 3D printing
method and can be divided into the following sub-types:
laser-guided bio-printing (LGB), biological laser processing
(BIoLP), laser-induced forward transfer (LIFT), and matrix-assisted pulsed laser evaporation direct writing
(MAPLEDW). LGB has low throughput but high resolution,
and can control single cells. LIFT has higher throughput
than LGB but a poor control of single cells. Heat generated
by laser pulse is transmitted to the thin films that coat the
cells and cut out cell droplets of particular sizes and shapes,
which attach to the movable basement. The heat might affect the viability of cells [37].
There is no nozzle on the acoustic bio-printer (Figure 2C).
The pressure of sound radiation can shake the cell ink and
controls the droplet size by adjusting acoustic frequency and
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amplitude. It generates little energy thus does not harm cells
[38]. At present, it has been used with many types of cells
and cell suspensions, and has been used in some other fields
such as manipulation of single cell DNA and RNA [39].
1.2

Bio-active scaffolds from 3D printing

Extracellular matrix (ECM) provides structural and biochemical support for cell growth and is composed of many
types of proteins and glycans. The alteration of ECM would
influence cell state and function [40,41]. With high resolution, 3D printing could be used to print scaffolds that mimic
in vivo structure and environment of tissues, and there are
many reports that scaffolds from 3D printing have been
used in drug delivery, tissue engineering and cell viability
tests [14,15]. Model fabrication is the first 3D printing application, with optimization of the technique and material
modification, some bio-active hard tissues have been printed [42]. In 2012, the first clinical trial of 3D bio-printing
was performed at a hospital in the Netherlands. A bionic
jaw printed using 3D printer was transplanted into a patient
(http://www.bbc.com/news/technology-16907104). Since
then, more trials have been performed in Japan, Poland and
some other countries (http://3dprint.com/19617/osteo3d3d-print-mouth/ and http://www.3ders.org/). The grafted
materials can specifically interact with vocal organs without
affecting the hearing and the vocality of patients [43].
To directly print the live tissues, many printed scaffolds
were used for cell culture. Cells obtain higher viability and
function when cultured on 3D scaffolds compared to
two-dimensional environments [44,45]. Ploy caprolactone
(PCL) scaffolds from printing have been used in culturing
different types of cells, as shown in Table 2. However, this
is just the combination of scaffolds with cells at the
two-dimensional level, and is therefore called indirect 3D
bio-printing. Actually, the interaction between cells and
materials in the indirect 3D printing is still two-dimensional
because only one side of the cell surround is scaffolds. Table 2 shows progress of application of 3D printing scaffolds
on cell culture and another bio-printing called direct 3D
bio-printing compared to indirect 3D bio-printing and the
direct 3D bio-printing shows that the cells are encapsulated
in materials and then are used as bio-ink.
1.3

Cell 3D bio-printing

There are more than 200 cell types in a human body, and
these cells form different and complicated tissues and organs. That makes it difficult to replicate complex and functional 3D tissues and organs in vitro. 3D bio-printing may
solve this problem. The ink droplets can deposit live cells
and fabricate the tissues and organs as desired. Despite a
promising future for organ transplantation, at the moment
there has been no biologically active organ fabricated by 3D
bio-printing. Each tissue and organ of the human body is
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sophisticated in construction, and the combinations of various types of cells require not only in vitro tests of viability
and functionality but also in vivo tests of interactions with
other tissues and organs. 3D printing has been widely used
in the manufacturing industry. It has also been used in the
bio-therapy field with hard and vessel-free structures. Gabor
Forgacs and colleagues [46] printed short blood vessels and
beating cardiac valves, demonstrating that cell-printing is
possible. They later established a company named Organovo, dedicated to bio-printer development and marketing.
Fibroblasts have been successfully printed by improving 3D
printers [47]. Cell sources have been extended to adult stem
cells and endothelial cells, and after printing, some cell-cell
interactions can be observed. These pave the way for future
3D organ-printing [48].
When the cells are encapsulated into the materials and
used for ink, we call this 3D bio-printing as direct 3D
bio-printing as shown in Table 2. One disadvantage of cell
encapsulated in materials is the loss of cell viability. Hydrogel is the first candidate for cell printing. To maintain
cell viability and cell-cell interactions, some hydrogel materials can be added into the ink. Hydrogels can also work as
substrates and scaffoldings [49]. Hydrogels have special
chemical and physical properties, and can be degraded in
vivo sometime after grafting. The initial materials used as
scaffoldings were electrospun fibers, for substituting blood
vessels [50]. Now collagen, ployanhydride and fibronectin
have been widely used. It is still a hot field nowadays
[51,52]. Below are some hydrogels having been used successfully in 2D fabrication via 3D printing technology and
the functions of the fabricated products could also be detected: culture medium [53], agarose [54], alginate [55],
collagen [56], matrigel [5759], fibrin [60], k-70 series [61]
and polyvinyl alcohol (PVA) [62]. After extruded from the
printer tips, hydrogels would be polymerized by cross-linker
[63]. It is a challenge to protect cells and to maintain the
resolution during hydrogel’s stabilization. Therefore, many
new modified-hydrogels and methods are being explored
[6466].
Hydrogel is a type of polymer that could contain much
water in the 3D structure. The mechanical properties and
bio-properties of hydrogel need to be modified for printing
and cell survival. At present, during printing and crosslinking there will be some cell death with a wide range
(~2%–40%) because the cells are outside various natural
environment [65,67,68]. There are chemical and physical
ways to crosslink hydrogels. Gelatin is water soluble protein
and has high biocompatibility [69]. With methacrylamide
group modified, the gelatin (gelMA) could be cross-linked
using ultraviolet rays [70]. The adding of hyaluronic acid
(HA) improves gelMA printable properties [65]. Calcium
could crosslink alginate and alginate-gelatin blends have
been reported as potential materials for extrusion printing
living cells [71,72]. Single cell printing has high resolution
and could be used for cell patterning and material-cell
blends precise control. Present technique “Block-Cell-
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Examples of 3D bio-printing
Types

Materials

Cells

Morphology

Ref.

Indirect

PCL

Myoblast cell line C2C12

[74]

Indirect

Calcium phosphate modified PCL
(PCL-CaP) treated with fibrinogen

Mesenchymal stem cells
(MSCs)

[75]

Indirect

PCL

MSCs

[76]

Indirect

Glycerol with soy protein

MSCs

Indirect

PCL and alginate

Osteoblast cells and chondrocyte

[78]

Indirect

Collagen and gelatin

There is no cell

[79]

Direct

Cell culture medium

Mouse embryonic stem cells
(mESCs)

[80]

Direct

Cells printed on PEUU immersed
in Matrigel

Human umbilical vein endothelial cells (hUVECs), MSCs

[81]

Direct

HA and gelMA

Chondrocyte

[65]

Direct

gelMA

Live cancer cell line, HepG2

[82]

Direct

Single cell pattern

A few breast cancer cell lines

[73]

[77]
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Printing” even makes cell 100% living after printing [73].

2 The future of 3D bio-printing
It takes a long time and needs lots of cells when accomplishing an organ-printing [83]. During such a long period
of time, how to ensure the accuracy of printing and the cell
viability have become the crucial questions. The jet nozzle
can be enveloped with aluminium alloy to prevent exposure
to the radiations from laser [84]. At present, complicated
tissue scaffoldings can be fabricated using hydrogels by
laser-mediated 3D bio-printer and inkjet 3D bio-printer
[79,8588]. Yet in the process of 3D fusion, the use of high
temperature and high pressure and some solvents may lead
to the death of cells [89]. Three-dimensional tissue printed
from a mixture of cells and hydrogels [78,90] possesses
mechanical properties similar to natural structures but with
limited cell expansion capabilities and function. This is one
of the major limitations faced by 3D bio-printing at the
moment [91]. Although many reports demonstrated the cells
could be printed, there is still no report about the function of
printed cells. At present, we could keep cells living in materials but we cannot direct the future state of cells [92]. Cell
states are dependent on the varied substrates, many materials are developed to mimic the ECM [9395], native tissue
derived bio-ink is also proposed to simulated the in vivo
environment [96]. Therefore, how to optimize the materials
for cells’ customization is one of future work.
Another issue of bio-printing is how to print organs containing blood vessels. Every organ needs the network of
vessels and capillaries to supply oxygen, cytokines and nutrients, as well as to remove the wastes which are noxious to
cells. It has been reported that cardiac muscle tissue containing vessel-like structure was obtained from endothelial
cells through tissue culture [31]. Fabrication of functional
3D tissues containing blood vessels is still a great challenge
faced by 3D bio-printing [97].
The key problem faced by 3D bio-printing is cell sources,
as cells are the basic units of an organ. Stem cells may become the primary source for bio-printing. Stem cells have
high viability and short cell cycle time, and can differentiate
into other cell types in defined conditions. This may reduce
the number of cells required in bio-printing, save printing
time, and create conditions for printed organs to function.
At present, initial trials have been performed in 3D
bio-printing with stem cells. Embryonic stem cells were
used in 3D printing to form embryoid bodies (EBs) [80].
Human mesenchymal stem cells (hMSCs) and human umbilical vein endothelial cells (hUVECs) were utilized to
print fabricated patches to repair cardiac muscles [81].
However, there is still a long way to go in choosing the
right stem cells for bio-printing the right organs.
Ideally 3D bio-printing involves in situ printing of cells
at the site of injury. This requires rapid model construction,
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rapid printing and sufficient cell sources. Fulfilment of such
requirements would lead to a revolution in regenerative
medicine. For example, a quick repair of the skin wound
with 3D bio-printing would increase the recovery rate and
reduce permanent scarring.
In the quest for optimised 3D bio-printing of tissues and
organs, how we characterize and evaluate the functions of
the printed organs is also an area that requires development
[98]. Relevant analyses shall include tests of cell viability,
cell tracking, functional marker detection and animal model
experiments. To accomplish 3D bio-printing of larger tissues structural scaffolds need to be utilised. Materials such
as degradable poly caprolactone (PCL) have been used
[7476,78].
Establishment of safety evaluation systems for testing 3D
bio-printed structures is another issue to be considered
[99,100]. Appropriate regulatory frameworks are yet to be
developed. 3D bio-printing is a new and complicated technology, and the process involves cell preparation, cell expansion, graft, materials and observation after grafting, and
safety and efficiency evaluation.
In summary, 3D bio-printing holds a great promising future. Real clinical advances require parallel advance in
many fields to occur.
This work was supported by the National Basic Research Program of
China (2011CB965000) and Chinese Academy of Sciences Strategic Priority Research Program Grants (XDA01030506).
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